Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure-based design, synthesis and antiproliferative action of new quinazoline-4-one/chalcone hybrids as EGFR inhibitors
Mohamed Hisham, Heba A. Hassan, Hesham A. M. Gomaa, et al.
Journal of Molecular Structure (2022) Vol. 1254, pp. 132422-132422
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Design, synthesis, and antiproliferative properties of new 1,2,3-triazole-carboximidamide derivatives as dual EGFR/VEGFR-2 inhibitors
Mohamed A. Mahmoud, Anber F. Mohammed, Ola I. A. Salem, et al.
Journal of Molecular Structure (2023) Vol. 1282, pp. 135165-135165
Closed Access | Times Cited: 24
Design and Synthesis of New Dihydropyrimidine Derivatives with a Cytotoxic Effect as Dual EGFR/VEGFR-2 Inhibitors
Lamya H. Al-Wahaibi, Ali M. Elshamsy, Taha F. S. Ali, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34358-34369
Open Access | Times Cited: 9
Design, synthesis, cytotoxic activities, and molecular docking of chalcone hybrids bearing 8-hydroxyquinoline moiety with dual tubulin/EGFR kinase inhibition
Mohammed M. Amin, Gamal El‐Din A. Abuo‐Rahma, Montaser Sh. A. Shaykoon, et al.
Bioorganic Chemistry (2023) Vol. 134, pp. 106444-106444
Closed Access | Times Cited: 15
Design, synthesis, and apoptotic antiproliferative action of new benzimidazole/1,2,3-triazole hybrids as EGFR inhibitors
Abubakar Ahmed, Anber F. Mohammed, Zainab M. Almarhoon, et al.
Frontiers in Chemistry (2025) Vol. 12
Open Access
Design, Synthesis and Evaluation of Quinazoline-Chalcone Hybrids as Inducers of Cell-Cycle Arrest and Apoptosis in Breast Cancer via DNA Damage and CDK2/ATR Inhibition
Giulia Rodrigues Stringhetta, Eduardo Bustos Mass, Izabela Natália Faria Gomes, et al.
European Journal of Medicinal Chemistry Reports (2025), pp. 100250-100250
Open Access
Design and Synthesis of New Quinazolinone Derivatives Conjugated with Chalcone or Pyridazine Moieties: Anticancer Activities and Apoptotic Induction
Dina S. M. Elazab, Dina I. A. Othman, Khalid B. Selim, et al.
Polycyclic aromatic compounds (2025), pp. 1-24
Closed Access
New s-Triazine/Tetrazole conjugates as potent antifungal and antibacterial agents: Design, molecular docking and mechanistic study
Ramadan Ahmed Mekheimer, Gamal El‐Din A. Abuo‐Rahma, Mohamed Abd‐Elmonem, et al.
Journal of Molecular Structure (2022) Vol. 1267, pp. 133615-133615
Closed Access | Times Cited: 22
Design, Synthesis, and Antiproliferative Activity of New 5-Chloro-indole-2-carboxylate and Pyrrolo[3,4-b]indol-3-one Derivatives as Potent Inhibitors of EGFRT790M/BRAFV600E Pathways
Lamya H. Al-Wahaibi, Anber F. Mohammed, Mostafa Abdelrahman, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1269-1269
Open Access | Times Cited: 14
A comprehensive review of recent advances in the biological activities of quinazolines
Hesham A. M. Gomaa
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 5, pp. 639-655
Closed Access | Times Cited: 18
Design, Synthesis, Molecular Modeling, and Anticancer Evaluation of New VEGFR-2 Inhibitors Based on the Indolin-2-One Scaffold
Mohamed A. Abdelgawad, Alaa M. Hayallah, Syed Nasir Abbas Bukhari, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1416-1416
Open Access | Times Cited: 18
Current scenario of chalcone hybrids with antibreast cancer therapeutic applications
Huan Wang, Juanying Zhu, Qianru Zhang, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 5
Closed Access | Times Cited: 3
EGFR as therapeutic target to develop new generation tyrosine kinase inhibitors against breast cancer: A critical review
Ruby Mariam Raju, Jeffin Joy A, Raghavendra Nulgumnalli Manjunathaiah, et al.
Results in Chemistry (2024) Vol. 7, pp. 101490-101490
Open Access | Times Cited: 3
Rational Design and Synthesis of Isatin‐Chalcone Hybrids Integrated with 1H‐1,2,3‐Triazole: Anti‐Proliferative Profiling and Molecular Docking Insights
Swati, Asif Raza, Shefali Chowdhary, et al.
ChemMedChem (2024) Vol. 19, Iss. 14
Closed Access | Times Cited: 3
Design and synthesis of new 1,2,4-oxadiazole/quinazoline-4-one hybrids with antiproliferative activity as multitargeted inhibitors
Amira M. Mohamed, Ola M. F. Abou‐Ghadir, Yaser A. Mostafa, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 3
One-Pot Synthesis of 1-Thia-4-azaspiro[4.4/5]alkan-3-ones via Schiff Base: Design, Synthesis, and Apoptotic Antiproliferative Properties of Dual EGFR/BRAFV600E Inhibitors
Lamya H. Al-Wahaibi, Essmat M. El‐Sheref, Mohamed M. Hammouda, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 467-467
Open Access | Times Cited: 9
Design, Synthesis, and Biological Evaluation of Novel Quinazolin-4(3H)-one-Based Histone Deacetylase 6 (HDAC6) Inhibitors for Anticancer Activity
Yogesh Mahadu Khetmalis, Ashna Fathima, Markus Schweipert, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11044-11044
Open Access | Times Cited: 9
Introducing Fe3O4@SiO2@KCC-1@MPTMS@CuII catalytic applications for the green one-pot syntheses of 2-aryl(or heteroaryl)-2,3-dihydroquinazolin-4(1H)-ones and 9-aryl-3,3,6,6-tetramethyl-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-diones
Morteza Hasanpour Galehban, Behzad Zeynizadeh, Hossein Mousavi
Journal of Molecular Structure (2022) Vol. 1271, pp. 134017-134017
Closed Access | Times Cited: 15
Novel 2‐[thio]acetamide linked quinazoline/1,2,4‐triazole/chalcone hybrids: Design, synthesis, and anticancer activity as EGFR inhibitors and apoptotic inducers
Ahmed S. Abdelkhalek, Hend Kothayer, Moustafa K. Soltan, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 7
Closed Access | Times Cited: 2
New series of 4,6-diaryl pyrimidines: facile synthesis and antiproliferative activity as dual EGFR/VEGFR-2 inhibitors
Yaser A. Mostafa, Abdeljalil Assoud, Ahmed Desoky, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 2
Design, synthesis, and modelling study of new 1,2,3‐triazole/chalcone hybrids with antiproliferative action as epidermal growth factor receptor inhibitors
Mohamed T.‐E. Maghraby, Ola I. A. Salem, Bahaa G. M. Youssif, et al.
Chemical Biology & Drug Design (2022) Vol. 101, Iss. 3, pp. 749-759
Closed Access | Times Cited: 10
Design, Synthesis, and Antiproliferative Activity of Quinazolin-4-One/Chalcone Hybrids via the EGFR Inhibition Pathway
Mohamed Hisham, Heba A. Hassan, Hesham A. M. Gomaa, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 17, pp. 1932-1943
Closed Access | Times Cited: 4
Metabolomic profiling and cytotoxic potential of three endophytic fungi of the genera Aspergillus, Penicillium and Fusarium isolated from Nigella sativa seeds assisted with docking studies
Nourhan Hisham Shady, Jianye Zhang, Sara Khalid Sobhy, et al.
Natural Product Research (2022) Vol. 37, Iss. 17, pp. 2905-2910
Closed Access | Times Cited: 6
Green Synthesis of 2‐Thioxo‐4‐quinazolinone Derivatives in Water
Kouhei Makiyama, Yuusuke Mimura, Yuuki Tomotani, et al.
ChemistrySelect (2023) Vol. 8, Iss. 17
Closed Access | Times Cited: 3
Design, Synthesis and Antitumor Activities of Novel Quinazolinone Derivatives as Potential EGFR Inhibitors
Jing Wang, Liwei Huang, Xi Chen, et al.
Chemical and Pharmaceutical Bulletin (2022) Vol. 70, Iss. 9, pp. 637-641
Open Access | Times Cited: 5
Design, Synthesis and Biological Evaluation of Syn and Anti-like Double Warhead Quinolinones Bearing Dihydroxy Naphthalene Moiety as Epidermal Growth Factor Receptor Inhibitors with Potential Apoptotic Antiproliferative Action
Essmat M. El‐Sheref, Mohamed A. Ameen, Kamal M. El‐Shaieb, et al.
Molecules (2022) Vol. 27, Iss. 24, pp. 8765-8765
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top